Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation

Journal of Experimental Medicine

Volumn 214, Issue 8, 2017, Pages 2315-2329

  Peng, Tao ^a,b   Chanthaphavong, R Savanh ^a   Sun, Sijie ^a   Trigilio, James A ^a   Phasouk, Khamsone ^b   Jin, Lei ^b   Layton, Erik D ^b   Li, Alvason Z ^b   Correnti, Colin E ^b   De van der Schueren, Willem ^b   Vazquez, Julio ^b   O'Day, Diana R ^a   Glass, Ian A ^a   Knipe, David M ^c   Wald, Anna ^a,b   Corey, Lawrence ^a,b   Zhu, Jia ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ANIMAL; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; KERATINOCYTE; METABOLISM; NEURITE; NEUROBLASTOMA; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

ANIMALS; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INTERLEUKIN-17; KERATINOCYTES; NEURITES; NEUROBLASTOMA; PERIPHERAL NERVOUS SYSTEM; VIRUS ACTIVATION;

EID: 85027351215     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20160581     Document Type: Article

References (39)

1. Abemayor, E., and N. Sidell. 1989. Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ. Health Perspect. 80:3-15. http ://dx.doi.org /10.1289 /ehp.89803
2. Bandaranayake, A.D., C. Correnti, B.Y. Ryu, M. Brault, R.K. Strong, and D.J. Rawlings. 2011. Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res. 39:e143. http ://dx.doi.org /10.1093 /nar /gkr706
3. Cabrera, J.R., A. Viejo-Borbolla, N. Martinez-Martín, S. Blanco, F. Wandosell, and A. Alcamí. 2015. Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection. PLoS Pathog. 11:e1004571. http ://dx.doi.org /10.1371 / journal.ppat.1004571
4. Cattin, A.L., J.J. Burden, L. Van Emmenis, F.E. Mackenzie, J.J. Hoving, N. Garcia Calavia, Y. Guo, M. McLaughlin, L.H. Rosenberg, V. Quereda, et al. 2015. Macrophage-induced blood vessels guide Schwann cellmediated regeneration of peripheral nerves. Cell. 162:1127-1139. http ://dx.doi.org /10.1016 /j.cell.2015.07.021
5. Chang, S.H., J.M. Reynolds, B.P. Pappu, G. Chen, G.J. Martinez, and C. Dong. 2011. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 35:611-621. http ://dx .doi.org /10.1016 /j.immuni.2011.09.010
6. Chen, C., E. Itakura, G.M. Nelson, M. Sheng, P. Laurent, L.A. Fenk, R.A. Butcher, R.S. Hegde, and M. de Bono. 2017. IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses. Nature. 542:43-48. http :// dx.doi.org /10.1038 /nature20818
7. Chuong, C.M., B.J. Nickoloff, P.M. Elias, L.A. Goldsmith, E. Macher, P.A. Maderson, J.P. Sundberg, H. Tagami, P.M. Plonka, K. Thestrup-Pederson, et al. 2002. What is the 'true' function of skin? Exp. Dermatol. 11:159-187.
8. Gaffen, S.L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9:556-567. http ://dx.doi.org /10.1038 /nri2586
9. Gaffen, S.L. 2011. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23:613-619. http ://dx.doi.org /10.1016 /j.coi.2011.07.006
10. Haanpää, M., P. Laippala, and T. Nurmikko. 1999. Pain and somatosensory dysfunction in acute herpes zoster. Clin. J. Pain. 15:78-84. http ://dx.doi .org /10.1097 /00002508 -199906000 -00003
11. Harrington, A.W., and D.D. Ginty. 2013. Long-distance retrograde neurotrophic factor signalling in neurons. Nat. Rev. Neurosci. 14:177-187. http ://dx.doi.org /10.1038 /nrn3253
12. Johnston, A., Y. Fritz, S.M. Dawes, D. Diaconu, P.M. Al-Attar, A.M. Guzman, C.S. Chen, W. Fu, J.E. Gudjonsson, T.S. McCormick, and N.L. Ward. 2013. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J. Immunol. 190:2252-2262. http ://dx.doi.org /10 .4049 /jimmunol.1201505
13. Johnston, C., M. Saracino, S. Kuntz, A. Magaret, S. Selke, M.L. Huang, J.T. Schiffer, D.M. Koelle, L. Corey, and A. Wald. 2012. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 379:641-647. http ://dx.doi.org /10.1016 /S0140 -6736(11)61750 -9
14. Koutsky, L.A., C.E. Stevens, K.K. Holmes, R.L. Ashley, N.B. Kiviat, C.W. Critchlow, and L. Corey. 1992. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. 326:1533- http ://dx.doi.org /10.1056 /NEJM199206043262305
15. Kurt-Jones, E.A., M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M.M. Arnold, D.M. Knipe, and R.W. Finberg. 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA. 101:1315-1320. http ://dx.doi.org /10.1073 /pnas.0308057100
16. Lloyd, C., Q.C. Yu, J. Cheng, K. Turksen, L. Degenstein, E. Hutton, and E. Fuchs. 1995. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol. 129:1329- http ://dx.doi.org /10.1083 /jcb.129.5.1329
17. Lund, J., A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki. 2003. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520. http ://dx.doi .org /10.1084 /jem.20030162
18. Magaret, A.S., A. Wald, M.L. Huang, S. Selke, and L. Corey. 2007. Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J. Clin. Microbiol. 45:1618-1620. http ://dx.doi.org /10 .1128 /JCM.01405 -06
19. Misery, L. 1997. Skin, immunity and the nervous system. Br. J. Dermatol. 137:843-850. http ://dx.doi.org /10.1111 /j.1365 -2133.1997.tb01542.x
20. Pappu, R., S. Rutz, and W. Ouyang. 2012. Regulation of epithelial immunity by IL-17 family cytokines. Trends Immunol. 33:343-349. http ://dx.doi .org /10.1016 /j.it.2012.02.008
21. Peng, T., J. Zhu, A. Klock, K. Phasouk, M.L. Huang, D.M. Koelle, A. Wald, and L. Corey. 2009. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J. Virol. 83:12559-12568. http ://dx.doi.org /10.1128 /JVI.00939 -09
22. Peng, T., J. Zhu, K. Phasouk, D.M. Koelle, A. Wald, and L. Corey. 2012. An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection. J. Virol. 86:10587- http ://dx.doi.org /10.1128 /JVI.01237 -12
23. Ramirez-Carrozzi, V., A. Sambandam, E. Luis, Z. Lin, S. Jeet, J. Lesch, J. Hackney, J. Kim, M. Zhou, J. Lai, et al. 2011. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 12:1159-1166. http ://dx.doi.org /10.1038 /ni.2156
24. Rasmussen, S.B., S.B. Jensen, C. Nielsen, E. Quartin, H. Kato, Z.J. Chen, R.H. Silverman, S. Akira, and S.R. Paludan. 2009. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene-like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90:74-78. http ://dx.doi.org /10.1099 /vir.0 .005389 -0
25. Reinert, L.S., L. Harder, C.K. Holm, M.B. Iversen, K.A. Horan, F. Dagnæs- Hansen, B.P. Ulhøi, T.H. Holm, T.H. Mogensen, T. Owens, et al. 2012. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122:1368-1376. http ://dx.doi.org /10.1172 /JCI60893
26. Roizman, B., and R.J. Whitley. 2013. An inquiry into the molecular basis of HSV latency and reactivation. Annu. Rev. Microbiol. 67:355-374. http :// dx.doi.org /10.1146 /annurev -micro -092412 -155654
27. Sato, A., M.M. Linehan, and A. Iwasaki. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA. 103:17343-17348. http ://dx.doi.org /10.1073 /pnas.0605102103
28. Schiffer, J.T., L. Abu-Raddad, K.E. Mark, J. Zhu, S. Selke, D.M. Koelle, A. Wald, and L. Corey. 2010. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes. Proc. Natl. Acad. Sci. USA. 107:18973-18978. http ://dx.doi.org /10.1073 /pnas.1006614107
29. Schiffer, J.T., D. Swan, R. Al Sallaq, A. Magaret, C. Johnston, K.E. Mark, S. Selke, N. Ocbamichael, S. Kuntz, J. Zhu, et al. 2013. Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. eLife. 2:e00288. http ://dx.doi .org /10.7554 /eLife.00288
30. Schmader, K. 1998. Postherpetic neuralgia in immunocompetent elderly people. Vaccine. 16:1768-1770. http ://dx.doi.org /10.1016 /S0264 -410X(98)00137 -6
31. Song, X., S. Zhu, P. Shi, Y. Liu, Y. Shi, S.D. Levin, and Y. Qian. 2011. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat. Immunol. 12:1151-1158. http :// dx.doi.org /10.1038 /ni.2155
32. Song, X., H. Gao, Y. Lin, Y. Yao, S. Zhu, J. Wang, Y. Liu, X. Yao, G. Meng, N. Shen, et al. 2014. Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity. 40:140-152. http ://dx.doi.org /10.1016 /j.immuni.2013.11 .018
33. Svensson, A., P. Tunbäck, I. Nordström, L. Padyukov, and K. Eriksson. 2012. Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection. J. Gen. Virol. 93:1717-1724. http ://dx.doi.org /10.1099 /vir.0.042572 -0
34. Tessier-Lavigne, M., and C.S. Goodman. 1996. The molecular biology of axon guidance. Science. 274:1123-1133. http ://dx.doi.org /10.1126 / science.274.5290.1123
35. Wald, A., L. Corey, R. Cone, A. Hobson, G. Davis, and J. Zeh. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99:1092-1097. http ://dx.doi .org /10.1172 /JCI119237
36. Zhu, J., D.M. Koelle, J. Cao, J. Vazquez, M.L. Huang, F. Hladik, A. Wald, and L. Corey. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204:595-603. http ://dx.doi.org /10.1084 /jem.20061792
37. Zhu, J., F. Hladik, A. Woodward, A. Klock, T. Peng, C. Johnston, M. Remington, A. Magaret, D.M. Koelle, A. Wald, and L. Corey. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15:886-892. http ://dx.doi.org /10.1038 /nm.2006
38. Zhu, J., T. Peng, C. Johnston, K. Phasouk, A.S. Kask, A. Klock, L. Jin, K. Diem, D.M. Koelle, A. Wald, et al. 2013. Immune surveillance by CD8aa+ skinresident T cells in human herpes virus infection. Nature. 497:494-497. http ://dx.doi.org /10.1038 /nature12110
39. Zochodne, D.W. 2008. Neurobiology of Peripheral Nerve Regeneration. Cambridge University Press, Cambridge, UK. http ://dx.doi.org /10 .1017 /CBO9780511541759